Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to reduce the severity of infections such as bird flu, and cure chronic conditions ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and CTI Clinical Trial and ...

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

The modern era of biobased innovation was catalyzed by policy action. In 1999, President Bill Clinton issued Executive Order ...

Building on its historic leadership to chronicle discoveries in molecular life science, the American Society for Biochemistry and Molecular Biology (ASBMB) today announced the upcoming launch of a new ...

Junk bonds have a reputation of trading similar to stocks with respect to volatility. But Treasuries are considered to be the safe haven asset (for now). Thus, when HYG outperforms IEI, it's ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

To ensure a smooth examination process, the board said that the date sheet provides adequate gaps between major subjects, ...

In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies ...

The schedule is released 110 days before commencement of the exams and is designed to avoid conflicts among more than 40,000 ...

The best value and growth stocks can balance risk and return and are reasonably priced and positioned with room to grow.